Assessment of Tumor Resistance and Stem Cells in Prostate Cancer
18 Years
N/A
Male
Prostate Cancer
Trial Information
Assessment of Tumor Resistance and Stem Cells in Prostate Cancer
OBJECTIVES:
- Collect prostate tissue and other biological specimens for assessment of biological
markers that may relate to tumor progression and resistance and for future isolation of
stem cells and biologic markers.
Biological samples, including serum and mononuclear cells and tumor tissue, are collected
before and during surgery. Specimens are frozen and stored indefinitely.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Undergoing routine prostatectomy or transurethral resection of the prostate (TURP)
PATIENT CHARACTERISTICS:
5.1.1 Patient is undergoing routine prostatectomy or TURP.
5.1.2 Patient is ≥ 18 years old.
5.1.3 Patient must give informed consent.
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Prospective
Outcome Measure:
Collection and freezing of tumor samples
Outcome Time Frame:
5 years
Safety Issue:
No
Principal Investigator
Isaac Kim, MD, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Cancer Institute of New Jersey
Authority:
United States: Institutional Review Board
Study ID:
CDR0000648129
NCT ID:
NCT00991315
Start Date:
December 2008
Completion Date:
December 2008
Related Keywords:
- Prostate Cancer
- prostate cancer
- Prostatic Neoplasms
Name | Location |
|---|---|
| Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School | New Brunswick, New Jersey 08903 |
